RSV clinical trials at UCSF
1 research study open to eligible people
RSV is a common virus that infects the lungs and breathing passages. UCSF is running studies testing azithromycin for severe RSV and studies measuring immune responses in children. These studies collect data on safety, breathing support, and lab tests.
Showing trials for
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
open to eligible people ages up to 2 years
The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.
San Francisco, California and other locations
Last updated: